>

ASHO develops new software capable of detecting pathologies in medical records with 99% reliability – #BHHMembersInitiatives

BHH member ASHO, a leading healthcare coding company, has developed software that, thanks to Artificial Intelligence (AI), can detect certain pathologies in patients’ medical records with 99% reliability. This software has been developed through a pilot test within the framework of a study being carried out by the Neurology Service of the Consorci Sanitari Alt Penedès-Garraf (Barcelona) to identify patients at risk of suffering a stroke.

To achieve such a high level of success, ASHO has analyzed around 4,000 clinical histories from the last 15 years at this hospital center of cases of stroke that have previously had atrial fibrillation. This pathology is described as an irregular and often very fast heart rhythm (arrhythmia) that can cause blood clots in the heart and is a condition that predisposes to stroke.

The director of ASHO‘s Artificial Intelligence area, Juli Climent, explains that this software streamlines the process of detecting patients with certain pathologies through their medical records: “in this case, detecting atrial fibrillation in so many medical records manually would have required a large investment of time because, in some cases, the coding of the pathology was not well recorded and required a review of the entire medical record”.

Highly transferable software

ASHO‘s Artificial Intelligence has demonstrated its success in this first pilot test, giving rise not only to its use in the Barcelona hospital, but also to its future use in other centers in the country and with other pathologies.

“Unlike other more complicated software, this one has a very specific applicability, so it is very transferable to other hospitals and other types of pathologies. The only requirement is that the clinical records must be in Spanish or Catalan,” Climent explains.

According to data from the Spanish Neurology Society (SEN), strokes are currently the second leading cause of death in Spain (the first in women), affecting around 120,000 people every year.

Discover more about ASHO in their website HERE.